Assembly Biosciences's total assets for Q2 2025 were $80.78M, a decrease of -18.42% from the previous quarter. ASMB total liabilities were $62.68M for the fiscal quarter, a -12.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.